Forget CDs: Ultra-Safe ETFs That Pay More and Lock Less
Investors are turning to ultra-safe ETFs for higher yields without locking up capital. Here are three reliable option...
Wash Sale Rule Etfs Applicability
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,393 articles
Defensive ETFs Worth Buying: 3 Picks for March 2026
Market volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
Bitcoin ETFs Outflows Billion: Should You Sell Now
A wave of bitcoin etfs outflows billion sent ripples through the market. This guide breaks down what happened, why it...
Bridger Dumps 301,000 Bath: A Big Market Move for Investors
Bridger Management quietly exited a large Bath & Body Works position in the fourth quarter, selling about 301,000 sha...
One Rule, Three Stocks: A Legendary Investor's Top Picks
A single, time-tested rule guides smart stock selection: buy high-quality businesses at fair prices. Here are three s...
Vanguard IShares ETFs Compared: Is There a Difference?
Two of the biggest S&P 500 ETFs dominate the core holdings landscape. This guide breaks down how Vanguard and iShares...
3 Dividend ETFs That Could Replace Bond Income in 2026
As bond yields drift, investors are eyeing dividend ETFs that could replace bond income in 2026. Learn how three top ...
Kennametal Stock 50% Gains: What the Fund Sale Signals
A large fund sold a substantial stake in Kennametal, igniting questions about the stock's trajectory. This article br...
Arteris Director Trims Stake: Insider Move Impact Today
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
Baillie Gifford Dumps 248,000 MELI Shares: What It Means for Investors
A big fund move can shift sentiment and pricing. This article breaks down the implications of baillie gifford dumps 2...
Global Alpha Dumps 229,000 Shares: Market Move Explained
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status